Page last updated: 2024-09-02

tadalafil and nitroglycerin

tadalafil has been researched along with nitroglycerin in 8 studies

Compound Research Comparison

Studies
(tadalafil)
Trials
(tadalafil)
Recent Studies (post-2010)
(tadalafil)
Studies
(nitroglycerin)
Trials
(nitroglycerin)
Recent Studies (post-2010) (nitroglycerin)
1,7423921,08912,6592,2401,398

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Abrams, J1
Kloner, RA2
Bedding, A; Braat, S; Effron, M; Emmick, J; Kloner, R; MacDonald, T; Mitchell, M; Patterson, D; Warner, M1
Antunes, E; Baracat, JS; Claudino, MA; De Nucci, G; Priviero, FB; Teixeira, CE; Webb, RC1
Antunes, E; Priviero, FB; Teixeira, CE; Toque, HA; Webb, RC; Zemse, SM1
Baker, PN; Ganzevoort, W; Gluud, C; Groom, KM; Jakobsen, JC; Kariya, CT; Kenny, LC; Leemhuis, AG; Magee, LA; Mol, BWJ; Papageorghiou, AT; Pels, A; Sharp, AN; von Dadelszen, P1

Reviews

4 review(s) available for tadalafil and nitroglycerin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.
    Circulation, 2004, Nov-09, Volume: 110, Issue:19

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Arteriosclerosis; Blood Pressure; Carbolines; Contraindications; Coronary Disease; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Endothelium, Vascular; Erectile Dysfunction; Heart Rate; Humans; Hypotension; Imidazoles; Isosorbide Dinitrate; Male; Molecular Structure; Myocardial Infarction; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilation; Vasodilator Agents

2004
Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
    The American journal of cardiology, 2005, Dec-26, Volume: 96, Issue:12B

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Erectile Dysfunction; Humans; Imidazoles; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents

2005
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy.
    The Cochrane database of systematic reviews, 2023, 07-10, Volume: 7

    Topics: Female; Fetal Death; Fetal Growth Retardation; Humans; Infant, Newborn; Nitric Oxide; Nitroglycerin; Placenta; Pregnancy; Premature Birth; Sildenafil Citrate; Tadalafil

2023

Trials

1 trial(s) available for tadalafil and nitroglycerin

ArticleYear
The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease.
    British journal of clinical pharmacology, 2005, Volume: 60, Issue:5

    Topics: Aged; Analysis of Variance; Blood Pressure; Carbolines; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Exercise Tolerance; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Phosphodiesterase Inhibitors; Tadalafil; Vasodilator Agents

2005

Other Studies

3 other study(ies) available for tadalafil and nitroglycerin

ArticleYear
Time course of the interaction between tadalafil and nitrates.
    Journal of the American College of Cardiology, 2004, Jun-02, Volume: 43, Issue:11

    Topics: Angina Pectoris; Carbolines; Drug Interactions; Erectile Dysfunction; Humans; Male; Nitroglycerin; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Research Design; Tadalafil; Time Factors; Vasodilator Agents

2004
Stimulation of soluble guanylyl cyclase by BAY 41-2272 relaxes anococcygeus muscle: interaction with nitric oxide.
    European journal of pharmacology, 2006, Jan-13, Volume: 530, Issue:1-2

    Topics: Animals; Carbachol; Carbolines; Colforsin; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Enzyme Activation; Enzyme Inhibitors; Guanylate Cyclase; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroglycerin; Oxadiazoles; Pyrazoles; Pyridines; Quinoxalines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Tadalafil; Tetrodotoxin

2006
Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
    Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:4

    Topics: Animals; Carbolines; Drug Evaluation, Preclinical; Enzyme Inhibitors; Guanylate Cyclase; Imidazoles; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitroglycerin; Oxadiazoles; Penile Erection; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; Quinoxalines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents

2009